Leukodystrophies: Pathogenesis, diagnosis, strategies, therapies, and future research directions

Journal of Child Neurology

Volumn 18, Issue 9, 2003, Pages 578-590

  Maria, Bernard L ^a   Deidrick, Kathleen McCann ^a   Moser, Hugo ^b   Naidu, Sakkubai ^b  

^a UNIVERSITY OF MISSOURI   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTOACYLASE; CEREBROSIDE SULFATASE; GALACTOSYLCERAMIDASE; GLIAL FIBRILLARY ACIDIC PROTEIN; LORENZO OIL; PROTEOLIPID;

ADRENOLEUKODYSTROPHY; BONE MARROW TRANSPLANTATION; CANAVAN DISEASE; CHILD; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; GENOTYPE; GLOBOID CELL LEUKODYSTROPHY; HORMONE SUBSTITUTION; HUMAN; LEUKODYSTROPHY; LEUKOENCEPHALOPATHY; MALE; METACHROMATIC LEUKODYSTROPHY; MOLECULAR GENETICS; MOUSE; NEWBORN SCREENING; NONHUMAN; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PELIZAEUS MERZBACHER DISEASE; PRIORITY JOURNAL; PROTEOMICS; STEM CELL TRANSPLANTATION; WHITE MATTER;

EID: 0141893614     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738030180090401     Document Type: Note

References (1)

1. McGuiness MC, Lu JF, Zhang HP, et al: Role of ALDP (ABCD1) and mitochondria in X-linked adrenoleukodystrophy. Mol Cell Biol 2003;23:744-753.